62 related articles for article (PubMed ID: 2109876)
1. Alterations of IgE immunoglobulin concentration in the serum after megavoltage radiotherapy with large-field technique in patients with Hodgkin's disease.
Krüsmann W; Slanina J; Nolte I
Strahlenther Onkol; 1990 Apr; 166(4):265-70. PubMed ID: 2109876
[TBL] [Abstract][Full Text] [Related]
2. [Changes in isoagglutinin titers after high-voltage therapy with the large-field technic in Hodgkin's disease patients].
Krüsmann W; Slanina J; Wannenmacher M; Nolte I
Strahlenther Onkol; 1988 Feb; 164(2):79-84. PubMed ID: 3125619
[TBL] [Abstract][Full Text] [Related]
3. [Changes in concentrations of IgM, IgA and IgM immune globulins after megavolt therapy with the large-field technic in patients with Hodgkin's disease].
Krüsmann W; Slanina J; Boser F; Löhr GW
Strahlenther Onkol; 1988 Jun; 164(6):323-9. PubMed ID: 3133799
[TBL] [Abstract][Full Text] [Related]
4. Increased serum IgE in Hodgkin's disease is of polyclonal origin.
Landaas TO; Grimmer O; Heier HE; Godal T
Acta Pathol Microbiol Scand C; 1979 Dec; 87(6):377-80. PubMed ID: 121023
[TBL] [Abstract][Full Text] [Related]
5. IgE levels in Hodgkin's disease.
Thomas MR; Steinberg P; Votaw ML; Bayne NK
Ann Allergy; 1976 Dec; 37(6):416-9. PubMed ID: 999061
[TBL] [Abstract][Full Text] [Related]
6. The metabolism of IgE in patients with immunodeficiency states and neoplastic conditions.
Iio A; Strober W; Broder S; Polmar SH
J Clin Invest; 1977 May; 59(5):743-55. PubMed ID: 404320
[TBL] [Abstract][Full Text] [Related]
7. [Questions and aspects of radiotherapy of adult patients with localized supradiaphragmatic stage (CS I/II) Hodgkin's disease. 1. Questions and aspects on indications for primary and adjuvant radiotherapy].
Glanzmann C; Lütolf UM
Strahlenther Onkol; 1993 Aug; 169(8):449-58. PubMed ID: 8356505
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's disease.
Viviani S; Bonfante V; Santoro A; Zanini M; Devizzi L; Di Russo AD; Soncini F; Villani F; Ragni G; Valagussa P; Bonadonna G
Cancer J Sci Am; 1999; 5(5):275-82. PubMed ID: 10526668
[TBL] [Abstract][Full Text] [Related]
9. [Clincal study on serum immunoglobulin E (IgE) concentrations in patients with malignant lymphoma with special reference to Hodgkin's disease (author's transl)].
Kimura I; Onoshi T; Tanizaki Y; Ueda N
Rinsho Ketsueki; 1975 Dec; 16(12):1117-23. PubMed ID: 1240980
[No Abstract] [Full Text] [Related]
10. [Present state of the wide-field megavoltage radiotherapy of Hodgkin's disease. Fundamentals, performance, side effects (author's transl)].
Wannenmacher M; Slanina J; Kuphal K; Bruggmoser G
Radiologe; 1978 Oct; 18(10):371-87. PubMed ID: 100827
[TBL] [Abstract][Full Text] [Related]
11. [Interleukin 4, total and allergen-specific immunoglobulin E antibodies in the blood of individuals with an atopic constitution].
Paranos S; Pravica V; Bonaci B; Stojković-Mostarica M
Srp Arh Celok Lek; 1998; 126(3-4):92-6. PubMed ID: 9863362
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease].
Wang WH; Li YX; Song YW; Jin J; Liu YP; Wang SL; Zhou LQ; Liu XF; Yu ZH; Han JZ
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):218-21. PubMed ID: 16875611
[TBL] [Abstract][Full Text] [Related]
13. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
[TBL] [Abstract][Full Text] [Related]
14. Incidence of second solid cancer in patients after treatment of Hodgkin's disease.
Glanzmann C; Veraguth A; Lütolf UM
Strahlenther Onkol; 1994 Mar; 170(3):140-6. PubMed ID: 8160093
[TBL] [Abstract][Full Text] [Related]
15. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
Mjaaland I; Ganser D; Freitag EM; Bohndorf W
Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
[TBL] [Abstract][Full Text] [Related]
16. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.
Brice P; Bastion Y; Divine M; Nedellec G; Ferrant A; Gabarre J; Reman O; Lepage E; Fermé C
Cancer; 1996 Sep; 78(6):1293-9. PubMed ID: 8826953
[TBL] [Abstract][Full Text] [Related]
17. G-CSF during large field radiotherapy reduces bone marrow recovery capacity.
Pape H; Orth K; Heese A; Heyll A; Kobbe G; Schmitt G; Niederbichler AD; Peiper M; Schwarz A; Boelke E
Eur J Med Res; 2006 Aug; 11(8):322-8. PubMed ID: 17052967
[TBL] [Abstract][Full Text] [Related]
18. Lung function and serum concentrations of different cytokines in patients submitted to radiotherapy and intermediate/high dose chemotherapy for Hodgkin's disease.
Villani F; Viola G; Vismara C; Laffranchi A; Di Russo A; Viviani S; Bonfante V
Anticancer Res; 2002; 22(4):2403-8. PubMed ID: 12174934
[TBL] [Abstract][Full Text] [Related]
19. Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884).
Aleman BM; Girinsky T; van der Maazen RW; Strijk S; Meijnders P; Bortolus R; Olofsen-van Acht MJ; Lybeert ML; Lievens Y; Eghbali H; Noordijk EM; Tomsic R; Meerwaldt JH; Poortmans PM; Smit WG; Pinna A; Henry-Amar M; Raemaekers JM; ;
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1184-90. PubMed ID: 15936157
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
